Announcements Trials

Browse Landscape

Status

Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Urticaria 1 Sarcoma 1 Prostatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Mastocytosis, Systemic 1 Mastocytosis 1 Histiocytoma, Malignant Fibrous 1 Colorectal Neoplasms 1 Angioedemas, Hereditary 1 Angioedema 1 Adenoma, Islet Cell 1

Interventions

Exercise 18 Drug Therapy 17 pembrolizumab 12 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Phlebotomy × Clear all

NCT02874729 2016-11-25

Assay Development for Cancer Biomarkers

King's College London

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡